DARE
Daré Bioscience, Inc.
2.11
2 x 1.56
2 x 2.68
bid
ask
+
0.00
0.00%
2 @ 08:07 AM
2.14 +0.03 (1.61%)
| Ytd | 9.33% | |
| 1y | -10.97% |
2.09
day range
2.21
1.27
52 week range
9.19
| Open | 2.09 | Prev Close | 2.11 | Low | 2.09 | High | 2.21 | Mkt Cap | 31.61M |
| Vol | 116.08K | Avg Vol | 642.78K | EPS | -0.91 | P/E | N/A | Forward P/E | -2.35 |
| Beta | 1.34 | Short Ratio | 0.64 | Inst. Own | 7.59% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-13 | 50-d Avg | 2.28 | 200-d Avg | 1.99 | 1yr Est | 21.33 |
| Income Statement | |||
| Total Revenue | 152.46K | ||
| Revenues (USD) | 152.46K | ||
| Cost of Revenue | 242.33K | ||
| Gross Profit | -89.87K | ||
| Operating Expenses | 2.91M | ||
| Research and Development Expense | 660.46K | ||
| Selling, General and Administrative Expense | 2.25M | ||
| Operating Income | -3.00M | ||
| Net Income | -3.00M | ||
| Net Income Common Stock | -3.00M | ||
| Net Income Common Stock (USD) | -3.00M | ||
| Consolidated Income | -3.00M | ||
| Earnings per Basic Share | -0.21 | ||
| Earnings per Basic Share (USD) | -0.21 | ||
| Earnings per Diluted Share | -0.21 | ||
| Earning Before Interest & Taxes (EBIT) | -3.00M | ||
| Earning Before Interest & Taxes (USD) | -3.00M | ||
| Weighted Average Shares | 14.52M | ||
| Weighted Average Shares Diluted | 14.52M | ||
| Balance Sheet | |||
| Cash and Equivalents | 18.52M | ||
| Cash and Equivalents (USD) | 18.52M | ||
| Trade and Non-Trade Receivables | 687.76K | ||
| Current Assets | 21.66M | ||
| Property, Plant & Equipment Net | 3.73M | ||
| Total Assets | 27.83M | ||
| Debt Current | 1.20M | ||
| Total Debt | 1.61M | ||
| Current Liabilities | 21.12M | ||
| Debt Non-Current | 418.25K | ||
| Total Liabilities | 27.09M | ||
| Accumulated Retained Earnings (Deficit) | -191.69M | ||
| Accumulated Other Comprehensive Income | -377.08K | ||
| Shareholders Equity | 734.45K | ||
| Shareholders Equity (USD) | 734.45K | ||
| Assets Non-Current | 6.17M | ||
| Total Debt (USD) | 1.61M | ||
| Liabilities Non-Current | 5.97M | ||
| Trade and Non-Trade Payables | 1.23M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 682.97K | ||
| Net Cash Flow from Financing | -715.47K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -6.19M | ||
| Issuance (Purchase) of Equity Shares | 94.89K | ||
| Issuance (Repayment) of Debt Securities | -1.08M | ||
| Net Cash Flow from Operations | -5.52M | ||
| Effect of Exchange Rate Changes on Cash | 44.54K | ||
| Share Based Compensation | 455.06K | ||